On This Page (4 sections)
If K < 3.3 mEq/L, HOLD INSULIN and give 20–40 mEq/h IV KCl until K >= 3.3
1,000–1,500 mL balanced crystalloid (Lactated Ringer's) IV bolus
0.14 units/kg/h continuous IV infusion (or 0.1 U/kg bolus + 0.1 U/kg/h)
Add D5W or D10W when glucose drops < 250 mg/dL to allow continued gap closure
3% Hypertonic Saline 5 mL/kg IV bolus over 10 min for headache/lethargy
Bottom-Line Clinical Pearl
Insulin does NOT treat dehydration; fluids do. Never start insulin if serum potassium is < 3.3 mEq/L—giving insulin drives potassium intracellularly and triggers fatal cardiac arrest. Administer 1000–1500 mL balanced crystalloid in the first hour. Continue insulin infusion until the ANION GAP CLOSES (< 12 mEq/L), not merely when glucose normalizes. When glucose reaches 200–250 mg/dL, add dextrose to the IV fluids. Watch for pediatric cerebral edema: treat immediately with 3% hypertonic saline (5 mL/kg).
Diabetic Ketoacidosis (DKA) results from absolute or relative insulin deficiency combined with counter-regulatory hormone excess (glucagon, catecholamines, cortisol), driving accelerated lipolysis and hepatic ketogenesis. Hyperosmolar Hyperglycemic State (HHS) involves sufficient basal insulin to suppress ketogenesis, but insufficient insulin to control hyperglycemia, leading to profound osmotic diuresis and lethal dehydration.
| Diagnostic Parameter | Mild DKA | Moderate DKA | Severe DKA | Hyperosmolar Hyperglycemic State (HHS) |
|---|---|---|---|---|
| Plasma Glucose | > 250 mg/dL (variable) | > 250 mg/dL | > 250 mg/dL | MARKEDLY ELEVATED (> 600–1000 mg/dL) |
| Arterial/Venous pH | 7.25–7.30 | 7.00–7.24 | < 7.00 | > 7.30 (normal to mildly reduced) |
| Serum Bicarbonate | 15–18 mEq/L | 10–14 mEq/L | < 10 mEq/L | > 18 mEq/L |
| Serum/Urine Ketones | Positive (Beta-hydroxybutyrate > 3.0 mmol/L) | Positive | Positive | Negative or weakly positive |
| Effective Serum Osmolality | Variable | Variable | Variable | > 320 mOsm/kg (Calculated: 2*Na + Glucose/18) |
| Anion Gap [Na - (Cl + HCO3)] | > 10–12 | > 12 | > 12 | Variable (often normal < 12) |
| Typical Fluid Deficit | 5–6 Liters (100 mL/kg) | 5–7 Liters | 6–8 Liters | MASSIVE: 8–12 Liters (10–15% body weight) |
| Mental Status | Alert | Alert to drowsy | Stupor or coma | Profound lethargy, stupor, coma, seizures |
Practice Recommendation
Euglycemic DKA (euDKA) Warning: Patients taking SGLT2 inhibitors (Empagliflozin, Dapagliflozin, Canagliflozin), pregnant females, or patients with severe prolonged starvation can develop life-threatening DKA with NORMAL or near-normal blood glucose (< 250 mg/dL). SGLT2 inhibitors promote massive glycosuria, masking hyperglycemia while severe ketoacidosis and volume depletion progress. Always check an anion gap and serum beta-hydroxybutyrate in any unwell diabetic taking an SGLT2 inhibitor.
Although whole-body potassium stores are massively depleted in DKA (deficit of 300–600 mEq due to osmotic diuresis and urinary losses), extracellular potassium initially appears normal or elevated due to extracellular shift driven by acidosis and insulin lack. Administering insulin immediately drives potassium back into cells. If insulin is given to a patient with low-normal or low potassium, extracellular levels plunge precipitously, causing fatal ventricular dysrhythmias and respiratory arrest.
| Baseline Serum Potassium | Action on Insulin Infusion | Potassium Administration Regimen | Clinical Rationale |
|---|---|---|---|
| < 3.3 mEq/L | HOLD INSULIN IMMEDIATELY | Administer 20–40 mEq/hour IV KCl until serum K >= 3.3 mEq/L | Absolute emergency. Giving insulin at K < 3.3 causes fatal cardiac arrest. |
| 3.3–5.3 mEq/L | Start/Continue Insulin Infusion | Add 20–30 mEq KCl per liter of IV maintenance fluid | Maintains serum potassium between 4.0 and 5.0 mEq/L during insulin therapy. |
| > 5.3 mEq/L | Start/Continue Insulin Infusion | Do NOT give potassium; check serum K every 2 hours | Potassium will fall naturally as insulin drives it intracellularly. |
| Phase | Timeframe | Fluid Selection & Rate | Clinical Target & Adjustments |
|---|---|---|---|
| Initial Resuscitation | Hour 0 to 1 | 1,000–1,500 mL of balanced crystalloid (Lactated Ringer's) | Restores intravascular volume and renal perfusion; decreases counter-regulatory hormones. |
| Maintenance Phase | Hours 2 to 4+ | 250–500 mL/hr based on corrected sodium | If corrected Na is normal or high: Use 0.45% NaCl. If corrected Na is low: Use balanced crystalloid. |
| Dextrose Addition | When Glucose < 250 mg/dL | Add 5% or 10% Dextrose (D5W/D10W with 0.45% NaCl) to IV fluids | CRITICAL: Maintain serum glucose 150–200 mg/dL while CONTINUING insulin infusion until the anion gap closes. |
| Two-Bag Method | Continuous | Bag 1: 0.45% NaCl + 20 mEq KCl. Bag 2: D10 0.45% NaCl + 20 mEq KCl | Titrate the ratio of Bag 1 and Bag 2 to keep blood glucose strictly between 150–200 mg/dL while running fixed-dose insulin. |
Administer regular human insulin as a continuous IV infusion at 0.14 units/kg/hour (or 0.1 units/kg bolus followed by 0.1 units/kg/hour). Target a gradual blood glucose decline of 50 to 75 mg/dL per hour. If glucose fails to decrease by 50 mg/dL in the first hour, verify IV line patency and double the insulin rate.
- Criteria for DKA Resolution: Blood glucose < 200 mg/dL, PLUS at least two of: 1) Serum bicarbonate >= 18 mEq/L; 2) Venous pH > 7.30; 3) Normal anion gap (<= 12 mEq/L).
- Subcutaneous Insulin Transition: Administer long-acting subcutaneous basal insulin (Glargine/Detemir at 0.2–0.3 units/kg) 2 hours BEFORE discontinuing the IV insulin infusion. Discontinuing the IV infusion without prior basal insulin coverage causes rapid rebound ketoacidosis within 30–60 minutes due to the ultra-short half-life of IV insulin (4–5 minutes).
Critical Pitfall / Contraindication
Pediatric Cerebral Edema Protocol: Cerebral edema occurs in 0.5–1.0% of pediatric DKA episodes (mortality 20–25%), typically 4–12 hours into therapy. Early warning signs: New headache, lethargy, irritability, incontinence, bradycardia, or sudden drop in GCS. Immediate management: 1) Administer 3% Hypertonic Saline (5 mL/kg IV over 10 min) OR Mannitol (0.5–1.0 g/kg IV over 20 min); 2) Elevate head of bed 30 degrees; 3) Reduce IV fluid infusion rate by 50%; 4) DO NOT DELAY treatment to obtain a head CT scan.
Test Your Diabetic Ketoacidosis (DKA) & Hyperosmolar Hyperglycemic State (HHS) Clinical Acumen
Directly launch an active-recall practice block from our validated question bank with comprehensive explanations and distractor analyses.
Distinguish primary life-threats from mimics. On board exams (COMLEX Level 1, 2-CE, 3 & USMLE), initial stabilizing interventions (airway, IV access, non-invasive ventilation, empiric reversal) always take precedence over diagnostic imaging.
Evaluate autonomic tone: Sympathetic viscerosomatics (T1–L2) cause acute paraspinal tissue texture changes (erythema, bogginess, hypertonicity). Suboccipital release (CN X Vagus) and rib raising normalize autonomic outflow and thoracic cage mechanics.